Twist Bioscience (NASDAQ:TWST – Get Free Report) had its target price lifted by investment analysts at Scotiabank from $43.00 to $48.00 in a report released on Monday, Benzinga reports. The firm presently has a “sector outperform” rating on the stock. Scotiabank’s target price would indicate a potential upside of 7.43% from the company’s current price. […]
Twist Bioscience (NASDAQ:TWST – Get Free Report) had its price target lifted by Scotiabank from $43.00 to $48.00 in a report released on Monday, Benzinga reports. The brokerage presently has a “sector outperform” rating on the stock. Scotiabank’s price objective would indicate a potential upside of 7.43% from the company’s current price. Several other equities […]
Twist Bioscience shares advanced nearly 26% in recent Friday trading, a day after the company reported fiscal Q2 results that topped estimates and increased its revenue outlook for fiscal.
Twist Bioscience (NASDAQ:TWST – Get Free Report) had its price objective hoisted by investment analysts at Evercore ISI from $46.00 to $50.00 in a research report issued to clients and investors on Friday, Benzinga reports. The firm currently has an “outperform” rating on the stock. Evercore ISI’s target price would indicate a potential upside of […]
Twist Bioscience (NASDAQ:TWST – Get Free Report) issued its quarterly earnings results on Thursday. The company reported ($0.79) EPS for the quarter, beating analysts’ consensus estimates of ($0.84) by $0.05, Briefing.com reports. The firm had revenue of $75.30 million for the quarter, compared to analysts’ expectations of $70.70 million. Twist Bioscience had a negative return […]